Cancer testing firm names chief scientific officer

NeoGenomics promotes Lawrence Weiss to lead scientific innovation initiatives.

  • By Business Observer Staff
  • | 6:00 a.m. December 19, 2018
  • | 0 Free Articles Remaining!
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — NeoGenomics, a leading provider of cancer-focused genetic testing services, named Dr. Lawrence Weiss chief scientific officer. Weiss has served as medical director and laboratory director for NeoGenomics Laboratories since joining NeoGenomics as part of its acquisition of Clarient in 2015.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • February 5, 2026
After changes, Boar’s Head reopens plant tied to listeria outbreak
  • February 5, 2026
Naples' David Hoffmann takes over Iowa newspaper chain
  • February 5, 2026
Tampa Bay Rays unveil stadium designs, plan to woo public
  • February 5, 2026
Lakeland man to pay $12.9M, go to prison for filing 450 fake tax returns

Sponsored Content